Biomarin Pharmaceutical Inc (BMRN) Insider Trading
- $1,316,196.75
- $342,139,664.94
- Nov. 12, 2024
- Jean Jacques Bienaime
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 28, 2017 | EVP | 18,415 | $92.43 | Sell | $1,702,098.45 | |
Sept. 22, 2017 | EVP | 3,521 | $95.00 | Sell | $334,495.00 | |
Sept. 15, 2017 | Insider | 15,000 | $90.50 | Sell | $1,357,500.00 | |
Sept. 15, 2017 | Director | 3,750 | $91.26 | Sell | $342,225.00 | |
June 23, 2017 | EVP | 9,844 | $96.60 | Sell | $950,930.40 | |
June 22, 2017 | SVP | 2,671 | $100.00 | Sell | $267,100.00 | |
June 19, 2017 | Insider | 15,000 | $90.00 | Sell | $1,350,000.00 | |
June 16, 2017 | Director | 3,750 | $90.00 | Sell | $337,500.00 | |
June 7, 2017 | EVP | 1,004 | $89.61 | Sell | $89,968.44 | |
June 5, 2017 | EVP | 9,471 | $91.04 | Sell | $862,239.84 | |
June 5, 2017 | CEO | 10,000 | $90.13 | Sell | $901,300.00 | |
May 24, 2017 | CEO | 5,000 | $88.38 | Sell | $441,900.00 | |
May 17, 2017 | CEO | 5,000 | $91.73 | Sell | $458,650.00 | |
May 8, 2017 | SVP | 7,482 | $91.87 | Sell | $687,371.34 | |
May 8, 2017 | CEO | 10,000 | $96.09 | Sell | $960,900.00 | |
May 5, 2017 | EVP | 2,500 | $100.34 | Sell | $250,850.00 | |
May 2, 2017 | EVP | 302 | $96.74 | Sell | $29,215.48 | |
April 27, 2017 | CEO | 5,000 | $95.72 | Sell | $478,600.00 | |
April 25, 2017 | CEO | 5,000 | $94.00 | Sell | $470,000.00 | |
March 29, 2017 | EVP | 3,890 | $89.15 | Sell | $346,793.50 | |
March 16, 2017 | EVP | 2,238 | $91.96 | Sell | $205,806.48 | |
March 16, 2017 | CFO | 1,989 | $91.96 | Sell | $182,908.44 | |
March 16, 2017 | CEO | 10,000 | $91.69 | Sell | $916,900.00 | |
March 10, 2017 | CEO | 11,000 | $90.59 | Sell | $996,490.00 | |
March 7, 2017 | EVP | 5,000 | $90.56 | Sell | $452,800.00 | |
March 6, 2017 | EVP | 1,498 | $93.32 | Sell | $139,793.36 | |
March 6, 2017 | CFO | 2,303 | $93.32 | Sell | $214,915.96 | |
March 1, 2017 | CFO | 35,000 | $94.07 | Sell | $3,292,450.00 | |
March 1, 2017 | Director | 7,500 | $95.00 | Sell | $712,500.00 | |
Feb. 24, 2017 | Insider | 15,000 | $87.99 | Sell | $1,319,850.00 | |
Jan. 26, 2017 | CEO | 10,000 | $84.22 | Sell | $842,200.00 | |
Jan. 11, 2017 | CEO | 8,000 | $90.58 | Sell | $724,640.00 | |
Jan. 9, 2017 | CEO | 8,000 | $88.49 | Sell | $707,920.00 | |
Jan. 9, 2017 | CFO | 5,000 | $90.00 | Sell | $450,000.00 | |
Dec. 30, 2016 | CEO | 8,000 | $83.60 | Sell | $668,800.00 | |
Nov. 22, 2016 | CEO | 69,743 | $85.69 | Sell | $5,976,277.67 | |
Nov. 21, 2016 | CEO | 69,744 | $87.56 | Sell | $6,106,784.64 | |
Nov. 8, 2016 | CEO | 140,000 | $82.67 | Sell | $11,573,800.00 | |
Nov. 7, 2016 | CEO | 70,000 | $82.52 | Sell | $5,776,400.00 | |
Oct. 28, 2016 | CEO | 120,000 | $81.30 | Sell | $9,756,000.00 | |
Oct. 17, 2016 | CEO | 41,666 | $84.39 | Sell | $3,516,193.74 | |
Oct. 14, 2016 | CEO | 64,125 | $86.96 | Sell | $5,576,310.00 | |
Sept. 29, 2016 | CEO | 53,125 | $93.65 | Sell | $4,975,156.25 | |
Sept. 27, 2016 | EVP | 18,467 | $95.61 | Sell | $1,765,629.87 | |
Sept. 16, 2016 | CEO | 137,368 | $95.34 | Sell | $13,096,665.12 | |
Aug. 26, 2016 | EVP | 15,000 | $95.06 | Sell | $1,425,900.00 | |
Aug. 16, 2016 | CEO | 41,666 | $91.49 | Sell | $3,812,022.34 | |
Aug. 1, 2016 | VP | 287 | $100.00 | Sell | $28,700.00 | |
Aug. 1, 2016 | CFO | 4,000 | $99.33 | Sell | $397,320.00 | |
Aug. 1, 2016 | EVP | 2,167 | $100.00 | Sell | $216,700.00 |
Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.
The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere
The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.
Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.
David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.
The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.
The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.
The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.